Epistaxis management on COVID-19-positive patients: Our early case experience and treatment #MMPMID32837722
Bathula SSR; Patrick T; Srikantha L
Clin Case Rep 2020[Nov]; 8 (11): 2195-2198 PMID32837722show ga
Epistaxis management on COVID-19 patients is concerning for otolaryngologists due to the highly virulence and increased concentration within respiratory droplets and nasal secretions. Authors suggest initial management with oxymetazoline nasal drops and local pressure before considering nasal packing with absorbable material to prevent COVID-19 transmission to surrounding healthcare workers.